{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:35:47Z","timestamp":1787578547160,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K12103"],"award-info":[{"award-number":["JP25K12103"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K14856"],"award-info":[{"award-number":["JP25K14856"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Daiwa Securities Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11302-026-10173-3","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:31:59Z","timestamp":1782711119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Responsiveness to adenosine diphosphate on carotid arterial and platelet functions in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats"],"prefix":"10.1007","volume":"22","author":[{"given":"Hideaki","family":"Tagashira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Tanaka-Totoribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9177-8384","authenticated-orcid":false,"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"10173_CR1","doi-asserted-by":"publisher","first-page":"115734","DOI":"10.1016\/j.biopha.2023.115734","volume":"168","author":"SA Antar","year":"2023","unstructured":"Antar SA, Ashour NA, Sharaky M et al (2023) Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother 168:115734","journal-title":"Biomed Pharmacother"},{"key":"10173_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X et al (2024) Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther 9:262","journal-title":"Signal Transduct Target Ther"},{"key":"10173_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0763-3","volume":"17","author":"R Kaur","year":"2018","unstructured":"Kaur R, Kaur M, Singh J (2018) Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol 17:121","journal-title":"Cardiovasc Diabetol"},{"key":"10173_CR4","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/j.1538-7836.2004.00836.x","volume":"2","author":"P Ferroni","year":"2004","unstructured":"Ferroni P, Basili S, Falco A et al (2004) Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2:1282\u20131291","journal-title":"J Thromb Haemost"},{"key":"10173_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11302-021-09807-5","volume":"17","author":"Z Zhou","year":"2021","unstructured":"Zhou Z (2021) Purinergic interplay between erythrocytes and platelets in diabetes-associated vascular dysfunction. Purinergic Signal 17:705\u2013712","journal-title":"Purinergic Signal"},{"key":"10173_CR6","doi-asserted-by":"publisher","first-page":"119237","DOI":"10.1016\/j.bbamcr.2022.119237","volume":"1869","author":"V Vultaggio-Poma","year":"2022","unstructured":"Vultaggio-Poma V, Falzoni S, Salvi G et al (2022) Signalling by extracellular nucleotides in health and disease. Biochim Biophys Acta Mol Cell Res 1869:119237","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10173_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","volume":"120","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic signaling in the cardiovascular system. Circ Res 120:207\u2013228","journal-title":"Circ Res"},{"key":"10173_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11302-015-9462-7","volume":"11","author":"G Burnstock","year":"2015","unstructured":"Burnstock G (2015) Blood cells: an historical account of the roles of purinergic signalling. Purinergic Signal 11:411\u2013434","journal-title":"Purinergic Signal"},{"key":"10173_CR9","doi-asserted-by":"publisher","first-page":"1537776","DOI":"10.3389\/fphar.2025.1537776","volume":"16","author":"Y Hou","year":"2025","unstructured":"Hou Y, Li H, Zhu L et al (2025) A review of natural compounds to regulate platelet aggregation: molecular mechanism and research advance. Front Pharmacol 16:1537776","journal-title":"Front Pharmacol"},{"key":"10173_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11302-023-09963-w","volume":"20","author":"I von K\u00fcgelgen","year":"2024","unstructured":"von K\u00fcgelgen I (2024) Pharmacological characterization of P2Y receptor subtypes - an update. Purinergic Signal 20:99\u2013108","journal-title":"Purinergic Signal"},{"key":"10173_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10557-021-07229-4","volume":"37","author":"X Li","year":"2023","unstructured":"Li X, Zhang G, Cao X (2023) The function and regulation of platelet P2Y12 receptor. Cardiovasc Drugs Ther 37:199\u2013216","journal-title":"Cardiovasc Drugs Ther"},{"key":"10173_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1748-1716.2012.02469.x","volume":"207","author":"K Ishida","year":"2013","unstructured":"Ishida K, Matsumoto T, Taguchi K et al (2013) Mechanisms underlying reduced P2Y(1)-receptor-mediated relaxation in superior mesenteric arteries from long-term streptozotocin-induced diabetic rats. Acta Physiol (Oxf) 207:130\u2013141","journal-title":"Acta Physiol (Oxf)"},{"key":"10173_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00424-022-02755-y","volume":"474","author":"T Matsumoto","year":"2022","unstructured":"Matsumoto T, Taguchi N, Ozawa K et al (2022) Indoxyl sulfate decreases uridine adenosine tetraphosphate-induced contraction in rat renal artery. Pflugers Arch 474:1285\u20131294","journal-title":"Pflugers Arch"},{"key":"10173_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/01.HYP.22.4.577","volume":"22","author":"JV Mombouli","year":"1993","unstructured":"Mombouli JV, Vanhoutte PM (1993) Purinergic endothelium-dependent and -independent contractions in rat aorta. Hypertension 22:577\u2013583","journal-title":"Hypertension"},{"key":"10173_CR15","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1248\/bpb.b16-00260","volume":"39","author":"S Watanabe","year":"2016","unstructured":"Watanabe S, Matsumoto T, Ando M et al (2016) A comparative study of vasorelaxant effects of ATP, ADP, and adenosine on the superior mesenteric artery of SHR. Biol Pharm Bull 39:1374\u20131380","journal-title":"Biol Pharm Bull"},{"key":"10173_CR16","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2337\/diab.41.11.1422","volume":"41","author":"K Kawano","year":"1992","unstructured":"Kawano K, Hirashima T, Mori S et al (1992) Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41:1422\u20131428","journal-title":"Diabetes"},{"key":"10173_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1124\/jpet.108.148718","volume":"329","author":"T Matsumoto","year":"2009","unstructured":"Matsumoto T, Nakayama N, Ishida K et al (2009) Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J Pharmacol Exp Ther 329:324\u2013334","journal-title":"J Pharmacol Exp Ther"},{"key":"10173_CR18","doi-asserted-by":"publisher","first-page":"H1480","DOI":"10.1152\/ajpheart.00229.2007","volume":"293","author":"T Matsumoto","year":"2007","unstructured":"Matsumoto T, Kakami M, Noguchi E et al (2007) Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes. Am J Physiol Heart Circ Physiol 293:H1480-1490","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10173_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2006.06.005","volume":"192","author":"T Matsumoto","year":"2007","unstructured":"Matsumoto T, Kobayashi T, Wachi H et al (2007) Vascular NAD(P)H oxidase mediates endothelial dysfunction in basilar arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Atherosclerosis 192:15\u201324","journal-title":"Atherosclerosis"},{"key":"10173_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.lfs.2013.11.016","volume":"118","author":"T Matsumoto","year":"2014","unstructured":"Matsumoto T, Watanabe S, Kawamura R et al (2014) Epigallocatechin gallate attenuates ET-1-induced contraction in carotid artery from type 2 diabetic OLETF rat at chronic stage of disease. Life Sci 118:200\u2013205","journal-title":"Life Sci"},{"key":"10173_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.2337\/diabetes.51.2.522","volume":"51","author":"YK Kim","year":"2002","unstructured":"Kim YK, Lee MS, Son SM et al (2002) Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes 51:522\u2013527","journal-title":"Diabetes"},{"key":"10173_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0306-3623(00)00061-6","volume":"34","author":"S Kagota","year":"2000","unstructured":"Kagota S, Yamaguchi Y, Nakamura K et al (2000) Altered endothelium-dependent responsiveness in the aortas and renal arteries of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of non-insulin-dependent diabetes mellitus. Gen Pharmacol 34:201\u2013209","journal-title":"Gen Pharmacol"},{"key":"10173_CR23","doi-asserted-by":"publisher","first-page":"e20240058","DOI":"10.21470\/1678-9741-2024-0058","volume":"40","author":"N Tanaka-Totoribe","year":"2025","unstructured":"Tanaka-Totoribe N, Nakamura E, Kuwabara M et al (2025) Optimal concentration of papaverine for the inhibition of internal thoracic artery vasospasm during coronary artery bypass graft surgery. Braz J Cardiovasc Surg 40:e20240058","journal-title":"Braz J Cardiovasc Surg"},{"key":"10173_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11302-020-09721-2","volume":"16","author":"T Matsumoto","year":"2020","unstructured":"Matsumoto T, Kojima M, Takayanagi K et al (2020) Impaired UTP-induced relaxation in the carotid arteries of spontaneously hypertensive rats. Purinergic Signal 16:453\u2013461","journal-title":"Purinergic Signal"},{"key":"10173_CR25","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1248\/bpb.b25-00490","volume":"48","author":"T Matsumoto","year":"2025","unstructured":"Matsumoto T, Nagano T, Tanaka-Totoribe N (2025) Effect of RANTES on vascular contractile and relaxant responses in rat carotid arteries. Biol Pharm Bull 48:1428\u20131434","journal-title":"Biol Pharm Bull"},{"key":"10173_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3400\/avd.ra.17-00134","volume":"11","author":"PM Vanhoutte","year":"2018","unstructured":"Vanhoutte PM (2018) Nitric oxide: from good to bad. Ann Vasc Dis 11:41\u201351","journal-title":"Ann Vasc Dis"},{"key":"10173_CR27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/j.1476-5381.1988.tb11756.x","volume":"95","author":"H Shimokawa","year":"1988","unstructured":"Shimokawa H, Flavahan NA, Lorenz RR et al (1988) Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig. Br J Pharmacol 95:1197\u20131203","journal-title":"Br J Pharmacol"},{"key":"10173_CR28","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1111\/bph.13205","volume":"172","author":"T Matsumoto","year":"2015","unstructured":"Matsumoto T, Goulopoulou S, Taguchi K et al (2015) Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. Br J Pharmacol 172:3980\u20134001","journal-title":"Br J Pharmacol"},{"key":"10173_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/apha.12646","volume":"219","author":"PM Vanhoutte","year":"2017","unstructured":"Vanhoutte PM, Shimokawa H, Feletou M et al (2017) Endothelial dysfunction and vascular disease - a 30th anniversary update. Acta Physiol (Oxf) 219:22\u201396","journal-title":"Acta Physiol (Oxf)"},{"key":"10173_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1476-5381.1987.tb11310.x","volume":"92","author":"MW Radomski","year":"1987","unstructured":"Radomski MW, Palmer RM, Moncada S (1987) Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92:181\u2013187","journal-title":"Br J Pharmacol"},{"key":"10173_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/01.HYP.11.6.573","volume":"6","author":"TF L\u00fcscher","year":"1988","unstructured":"L\u00fcscher TF, Diederich D, Weber E et al (1988) Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension 6:573\u2013578","journal-title":"Hypertension"},{"key":"10173_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/CS20110621","volume":"123","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Nemoto S, Ishida K et al (2012) Involvement of CaM kinase II in the impairment of endothelial function and eNOS activity in aortas of Type 2 diabetic rats. Clin Sci 123:375\u2013386","journal-title":"Clin Sci"},{"key":"10173_CR33","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/CIRCULATIONAHA.108.764571","volume":"119","author":"CG da Silva","year":"2009","unstructured":"da Silva CG, Specht A, Wegiel B et al (2009) Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells. Circulation 119:871\u2013879","journal-title":"Circulation"},{"key":"10173_CR34","doi-asserted-by":"publisher","first-page":"32209","DOI":"10.1074\/jbc.M109.032656","volume":"284","author":"CN Hess","year":"2009","unstructured":"Hess CN, Kou R, Johnson RP et al (2009) ADP signaling in vascular endothelial cells: ADP-dependent activation of the endothelial isoform of nitric-oxide synthase requires the expression but not the kinase activity of AMP-activated protein kinase. J Biol Chem 284:32209\u201332224","journal-title":"J Biol Chem"},{"key":"10173_CR35","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1016\/j.bbamcr.2013.06.009","volume":"1833","author":"R Bret\u00f3n-Romero","year":"2013","unstructured":"Bret\u00f3n-Romero R, Kalwa H, Lamas S et al (2013) Role of PTEN in modulation of ADP-dependent signaling pathways in vascular endothelial cells. Biochim Biophys Acta 1833:2586\u20132595","journal-title":"Biochim Biophys Acta"},{"key":"10173_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejphar.2008.06.031","volume":"591","author":"PK Gupta","year":"2008","unstructured":"Gupta PK, Subramani J, Leo MD et al (2008) Role of voltage-dependent potassium channels and myo-endothelial gap junctions in 4-aminopyridine-induced inhibition of acetylcholine relaxation in rat carotid artery. Eur J Pharmacol 591:171\u2013176","journal-title":"Eur J Pharmacol"},{"key":"10173_CR37","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/j.1538-7836.2010.03806.x","volume":"8","author":"O Dangel","year":"2010","unstructured":"Dangel O, Mergia E, Karlisch K et al (2010) Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition. J Thromb Haemost 8:1343\u20131352","journal-title":"J Thromb Haemost"},{"key":"10173_CR38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1006\/bbrc.2000.3976","volume":"279","author":"N Sogo","year":"2000","unstructured":"Sogo N, Magid KS, Shaw CA (2000) Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Biochem Biophys Res Commun 279:412\u2013419","journal-title":"Biochem Biophys Res Commun"},{"key":"10173_CR39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s002100100485","volume":"364","author":"F Yamaki","year":"2001","unstructured":"Yamaki F, Kaga M, Horinouchi T et al (2001) MaxiK channel-mediated relaxation of guinea-pig aorta following stimulation of IP receptor with beraprost via cyclic AMP-dependent and -independent mechanisms. Naunyn Schmiedebergs Arch Pharmacol 364:538\u2013550","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10173_CR40","doi-asserted-by":"publisher","first-page":"H2198","DOI":"10.1152\/ajpheart.00507.2008","volume":"295","author":"E Gomez","year":"2008","unstructured":"Gomez E, Schwendemann C, Roger S et al (2008) Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats. Am J Physiol Heart Circ Physiol 295:H2198-2211","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10173_CR41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fphar.2015.00266","volume":"6","author":"Z Raslan","year":"2015","unstructured":"Raslan Z, Aburima A, Naseem KM (2015) The spatiotemporal regulation of cAMP signaling in blood platelets-old friends and new players. Front Pharmacol 6:266","journal-title":"Front Pharmacol"},{"key":"10173_CR42","first-page":"162","volume":"32","author":"B Estevez","year":"2017","unstructured":"Estevez B, Du X (2017) New concepts and mechanisms of platelet activation signaling. Physiology (Bethesda) 32:162\u2013177","journal-title":"Physiology (Bethesda)"},{"key":"10173_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.thromres.2011.11.002","volume":"129","author":"K Broos","year":"2012","unstructured":"Broos K, De Meyer SF, Feys HB et al (2012) Blood platelet biochemistry. Thromb Res 129:245\u2013249","journal-title":"Thromb Res"},{"key":"10173_CR44","doi-asserted-by":"publisher","first-page":"462","DOI":"10.2337\/db06-0390","volume":"56","author":"A Michno","year":"2007","unstructured":"Michno A, Bielarczyk H, Pawe\u0142czyk T et al (2007) Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes. Diabetes 56:462\u2013467","journal-title":"Diabetes"},{"key":"10173_CR45","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/CIRCULATIONAHA.116.026995","volume":"136","author":"L Hu","year":"2017","unstructured":"Hu L, Chang L, Zhang Y et al (2017) Platelets express activated P2Y12 receptor in patients with diabetes mellitus. Circulation 136:817\u2013833","journal-title":"Circulation"},{"key":"10173_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/biof.5520310205","volume":"31","author":"MR Schetinger","year":"2007","unstructured":"Schetinger MR, Morsch VM, Bonan CD et al (2007) NTPDase and 5\u2019-nucleotidase activities in physiological and disease conditions: new perspectives for human health. BioFactors 31:77\u201398","journal-title":"BioFactors"},{"key":"10173_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0049-3848(03)00178-6","volume":"109","author":"GI Lunkes","year":"2003","unstructured":"Lunkes GI, Lunkes D, Stefanello F et al (2003) Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 109:189\u2013194","journal-title":"Thromb Res"},{"key":"10173_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2003.11.016","volume":"65","author":"GI Lunkes","year":"2004","unstructured":"Lunkes GI, Lunkes DS, Morsch VM et al (2004) NTPDase and 5\u2019-nucleotidase activities in rats with alloxan-induced diabetes. Diabetes Res Clin Pract 65:1\u20136","journal-title":"Diabetes Res Clin Pract"},{"key":"10173_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11010-006-9357-6","volume":"298","author":"VR Miron","year":"2007","unstructured":"Miron VR, Bauermann L, Morsch AL et al (2007) Enhanced NTPDase and 5\u2019-nucleotidase activities in diabetes mellitus and iron-overload model. Mol Cell Biochem 298:101\u2013107","journal-title":"Mol Cell Biochem"},{"key":"10173_CR50","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.diabres.2008.06.001","volume":"81","author":"GI Lunkes","year":"2008","unstructured":"Lunkes GI, Lunkes DS, Leal D et al (2008) Effect of high glucose levels in human platelet NTPDase and 5\u2019-nucleotidase activities. Diabetes Res Clin Pract 81:351\u2013357","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10173-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10173-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10173-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:14:14Z","timestamp":1787577254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-026-10173-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10173"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10173-3","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The operating procedures involved in this study were approved by the Laboratory Animal Use and Management Committee of the Institute of Kyushu University of Medical Science (approval numbers: 6\u20131-35 and 7\u20131-10).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"60"}}